This further suggested that there is no defect in the proliferation of tumor cells in LSL-Kras, Rb1∆L/∆L mice, and activation of oncogenic Kras can initiate senescence in these lesions similar to those in LSL-Kras, Rb1+/+ controls. The gene discussed is KRAS; the disease is neoplasm.